glp-1 obesity drug news october 21 2025 Weighty issue: drugs are reshaping packaging demand GLP-1 Drugs: 2025 Pulse Survey

Then, measurements (hallmarks of skin and nail aging, dermal density, skin moisture, elasticity, wrinkles, and nail color) were conducted at baseline, 4 weeks, and then 12 weeks

IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)

The term fetal alcohol effects (FAE) was used for alcohol-related neurodevelopmental disorder and alcohol-related birth defects

Frankly speaking, the results of this paper were obtained from animal experimental models, which is the greatest limitation of this study